Treatment of GLP-1 for Diabetic Bariatric Patients

Treatment of GLP-1 for Diabetic Bariatric Patients

Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: Semaglutide (1 Mg Dose); Drug: Placebo
Sponsors: Geisinger Clinic; Novo Nordisk A/S
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 15, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments